Ligand Pharmaceuticals LGND After 1 Year through 5 Years
After 1 Year through 5 Years at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's after 1 year through 5 years.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's after 1 year through 5 years?
- Ligand Pharmaceuticals (LGND) reported after 1 year through 5 years of $237M in Q1 2026.
- How has Ligand Pharmaceuticals's after 1 year through 5 years changed year-over-year?
- Ligand Pharmaceuticals's after 1 year through 5 years increased by 4934.0% year-over-year, from $4.71M to $237M.